A Novel Vaccine Delivery System Using Immunopotentiating Fusogenic Liposomes
- 11 August 1999
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 261 (3), 824-828
- https://doi.org/10.1006/bbrc.1999.1044
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Uehara Memorial Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 23 references indexed in Scilit:
- Efficient Gene Transfer into Mammalian Cells Using Fusogenic LiposomeBiochemical and Biophysical Research Communications, 1996
- HIV Preventive VaccinesDrugs, 1995
- Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.JCI Insight, 1992
- Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb moleculeNature, 1990
- IMMUNOGENICITY OF A KILLED HEPATITIS A VACCINE IN SERONEGATIVE VOLUNTEERSThe Lancet, 1989
- The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variationImmunology Today, 1988
- Functional activityin vivo of effector T cell populations III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte cloneEuropean Journal of Immunology, 1987
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Elicitation of primary anti‐Sendai virus cytotoxic T lymphocytes with purified viral glycoproteinsEuropean Journal of Immunology, 1980
- Non-infectious virus induces cytotoxic T lymphocytes and binds to target cells to permit their lysisNature, 1977